A comparison of Midazolam with remifentanil for the prevention of myoclonic movements following etomidate injection

Journal of International Medical Research

Volumn 36, Issue 1, 2008, Pages 17-22

  Hwang, J H ^a   Kim, J H ^a   Oh, A Y ^a   Do, S H ^a   Jeon, Y T ^a   Han, Sung Hee ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

Anaesthetic agents; Etomidate; Midazolam; Myoclonus; Remifentanil; Surgery

Indexed keywords

ATROPINE; BENZODIAZEPINE; ETOMIDATE; MIDAZOLAM; OPIATE; REMIFENTANIL;

ADULT; ANESTHESIA INDUCTION; ARTICLE; BRADYCARDIA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MUSCLE RIGIDITY; MYOCLONUS; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT;

EID: 39149108146     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000803600103     Document Type: Article

References (15)

1. Schwarzkopf KR, Hueter L, Simon M, et al: Midazolam pretreatment reduces etomidate-induced myoclonic movements. Anaesth Intensive Care 2003; 31: 18-20.
2. Doenicke AW, Roizen MF, Kugler J, et al: Reducing myoclonus after etomidate. Anesthesiology 1999; 90: 113-119.
3. Stockham RJ, Stanley TH, Pace NL, et al: Fentanyl pretreatment modifies anaesthetic induction with etomidate. Anaesth Intensive Care 1988; 16: 171-176.
4. Giese JL, Stockham RJ, Stanley TH, et al: Etomidate versus thiopental for induction of anesthesia. Anesth Analg 1985; 64: 871-876.
5. Berry JM, Merin RG: Etomidate myoclonus and the open globe. Anesth Analg 1989; 69: 256-259.
6. Hueter L, Schwarzkopf K, Simon M, et al: Pretreatment with sufentanil reduces myoclonus after etomidate. Acta Anaesthesiol Scand 2003; 47: 482-484.
7. Kelsaka E, Karakaya D, Sarihosan B, et al: Remifentanil pretreatment reduces myoclonus after etomidate. J Clin Anesth 2006; 18: 83-86.
8. Korttila K, Tammisto T, Aromaa U: Comparison of etomidate in combination with fentanyl or diazepam, with thiopentone as an induction agent for general anaesthesia. Br J Anaesth 1979; 51: 1151-1157.
9. Fassoulaki A, Pateras C, Kaniaris P: Fentanyl in the prevention of etomidate-induced myoclonus. Cah Anesthesiol 1987; 35: 201-202 [in French].
10. Aissaoui Y, Belyamani L, El Wali A, et al: Prevention of myoclonus after etomidate using a priming dose. Ann Fr Anesth Reanim 2006; 25: 1041-1045 [in French, English abstract].
11. Joshi GP, Warner DS, Twersky RS, et al: A comparison of the remifentanil and fentanyl adverse effect profile in a multicenter phase IV study. J Clin Anesth 2002; 14: 494-499.
12. Chung F, Mulier JP, Scholz J, et al: A comparison of anaesthesia using remifentanil combined with either isoflurane, enflurane or propofol in patients undergoing gynaecological laparoscopy, varicose vein or arthroscopic surgery. Acta Anaesthesiol Scand 2000; 44: 790-798.
13. Schuttler J, Albrecht S, Breivik H, et al: A comparison of remifentanil and alfentanil in patients undergoing major abdominal surgery. Anaesthesia 1997; 52: 307-317.
14. Davis PJ, Lerman J, Suresh S, et al: A randomized multicenter study of remifentanil compared with alfentanil, isoflurane, or propofol in anesthetized pediatric patients undergoing elective strabismus surgery. Anesth Analg 1997; 84: 982-989.
15. Raza SM, Zsigmond EK, Barabas E: Midazolam causes no adverse hemodynamic effects in cardiac patients. Clin Ther 1987; 10: 40-43.